2024 Intervention Selection & Sequencing in Early Stage NSCLC

Total Health

J. Porter

ASCO® 2024 Lung Cancer Highlights: Top Abstracts Including BEAT-SC, …

2024 ASCO® Annual Meeting Insights Hub

B. Halmos

Updates in the Management of NSCLC: Systemic Therapy Year in Review

Total Health

W. Iams

ASCO® 2023 Insights: "ADAURA Trial Key Learnings & Clinical Implicat…

Insights from 2023 ASCO® Annual Meeting

J. West

Recent NSCLC Updates Including PAPILLON, CHECKMATE 77T, and KEYNOTE-…

ecancer

L. Raez

PACIFIC Trial 5-Year OS Data: Clinical Implications in NSCLC

John Conibear

Neoadjuvant Chemoimmunotherapy in Unresectable NSCLC

MI&T Congressi

I. Opitz

ADAURA & KEYNOTE-671 Trials: Early Stage NSCLC Updates - 2023 ASCO® …

Total Health

J. Bauman

ASCO® 2023 Summary: "Expert Discussion on New Treatment Options for …

Insights from 2023 ASCO® Annual Meeting

D. Carbone, B. Stiles

Current Recommendations on Managing Dermatologic Adverse Reactions A…

Fawzi Abu Rous

Novel Early Management of Lung Cancer

Wenhua Liang

How Does PD-L1 Score Affect Treatment Options for NSCLC

GRACE

S. Patel, T. Leal, P. Iyengar, A. Desai, C. Kim, J. Rotow

ASCO® 2024 Insights: "Impact on Biomarker Documentation in Community…

2024 ASCO® Annual Meeting Insights Hub

D. Rubin

ASCO® 2024 Insights: "LIBRETTO-432 Trial - Adjuvant Selpercatinib vs…

2024 ASCO® Annual Meeting Insights Hub

J. Goldman

Thoracic Surgery Updates From Recent NSCLC Trials

OncoAlert

B. Stiles

New Drugs as Maintenance Therapy After CRT in Stage III NSCLC

MI&T Congressi

F. Barlesi

Treatment Strategies for Early Stage NSCLC

2023 Evolution Conference

N. Seetharamu

Oligometastatic Lung Cancer & Stereotactic Radiation Therapy Utiliza…

Luis Raez

ASCO 2022 on Immunotherapy Updates in Advanced NSCLC

Nebraska Oncology Society

J. Brahmer

ASCO® 2023 Insights: "Dr. Roy Herbst on ADAURA Trial OS Analysis of …

ecancer

R. Herbst